Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
Purpose. To evaluate antiangiogenic effect of local use of bevacizumab (anti-VEGF antibody) in patients with corneal neovascularization. Methods. Patients were divided into two groups. All patients suffered from some form of corneal neovascularization (NV). Patients in group A received 0.2–0.5 mL of...
שמור ב:
| Principais autores: | , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2014-01-01
|
| סדרה: | Journal of Ophthalmology |
| גישה מקוונת: | http://dx.doi.org/10.1155/2014/178132 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|